TGF-β is able to bind to its receptors and activate downstream Smad proteins (Smad2 or Smad3) via phosphorylation and nuclear translocation [27], and studies have indicated that the TGF-β/Smad pathway is crucial in controlling HCC growth and progression [28]. Here, SMAD2 is linked to hepatocellular carcinoma.